A cardiovascular life history; a life course analysis of the original Framingham Heart Study cohort

European Heart Journal

Volumn 23, Issue 6, 2002, Pages 458-466

  Peeters, Anna ^a,c   Mamun, A A ^b   Willekens, F ^b   Bonneux, L ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular diseases; Morbidity; Mortality; Population; Prevention

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; FEMALE; GENDER; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; STROKE;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE EXPECTANCY; LIFE TABLES; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGED; PREVALENCE; SURVIVAL ANALYSIS;

EID: 0036522140     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2838     Document Type: Article

References (22)

1. Dawber T, Moore F, Mann G. Measuring the risk of coronary heart disease in adult population groups. II Coronary heart disease in the Framingham study. Am J Pub Health 1957; 47: 4-24.
2. Doyle J, Heslin A, Hilleboe H, Formel P, Korns R. Measuring the risk of coronary heart disease in adult population groups. III A prospective study of degenerative cardiovascular disease in Albany: Report of three years experience I. Ischaemic heart disease. Am J Pub Health 1957; 47: 25-32.
3. Chapman J, Goerke L, Dixon W, Loveland D, Phillips E. Measuring the risk of coronary heart disease in adult population groups IV. The clinical status of a population group in Los Angeles under observation for two or three years. Am J Pub Health 1957; 47: 33-42.
4. Drake R, Buechley R, Breslow L. Measuring the risk of coronary heart disease in adult population groups V. An epidemiological investigation of coronary heart disease in the California health survey population. Am J Pub Health 1957; 47: 43-63.
5. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: Meta-analysis of randomised trials. Br Med J 2000; 321: 1-5.
6. Chalmers J, MacMahon S, Mancia G et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21: 1009-60.
7. Hooper L, Summerbell CD, Higgins JP et al. Reduced or modified dietary fat for prevention of cardiovascular disease. Cochrane Database Systematic Reviews 2000; 2: CD002137.
8. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction. Arch Intern Med 2000; 160: 939-44.
9. Lightwood J, Glantz S. Short-term economic and health benefits of smoking cessation. Myocardial infarction and stroke. Circulation 1997; 96: 1089-96.
10. Anderson K, Wilson P, Odell P, Kannel W. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-62.
11. Kannel W, Neaton J, Wentworth D et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325 348 men screened for the MRFIT. Am Heart J 1986; 112: 825-36.
12. Murray C, Lopez A. The Global Burden of Disease. Harvard: Harvard School of Public Health, 1996.
13. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham study 16 years follow-up. In: Kannel W, Gordon T, eds. The Framingham Study: An epidemiological investigation of cardiovascular disease. Washington, D.C.: US Government Printing Office, 1971.
14. Clayton D. Schifflers E. Models for temporal variation in cancer rates I: Age-period and age-cohort models. Stats Med 1987; 6: 449-67.
15. Willekens F. Life table analysis of staging processes. In: Becker HA, ed., Life histories and generations. Utrecht: Rijksuniversiteit te Utrecht, 1991.
16. Chiang C. The Life Table and Its Applications. Florida: Robert E Kreigler Publishing Company, 1984.
17. Davis R, FD H, Lip G. ABC of heart failure. History and epidemiology. Br Med J 2000; 320: 39-42.
18. Leaverton P, Sorlie P, Kleinman J et al. Representativeness of the Framingham risk model for coronary heart disease mortality: A comparison with a national cohort study. J Chron Dis 1987; 40: 775-84.
19. Lloyd-Jones D, Larson M, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999; 353: 89-92.
20. Rosamond W, Chambless L, Folsom A et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-7.
21. McGovern P, Pankow J, Shahar E et al. Recent trends in acute coronary heart disease. Mortality, morbidity, medical care and risk factors. N Engl J Med 1996; 334: 884-90.
22. Sytowski P, Kannel W, D'Agostino R. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990; 322: 1635-41.